A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

and for the treatment of patients with unresectable, Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation ...

Concurrently, mediastinal lymphadenopathy was observed. Given the suspicion of mediastinal lymphoma, a mediastinoscopy with lymph node biopsy was performed. Following a negative biopsy result, ...

Although usually identified early, skin lymphomas can be mistaken for other skin conditions, delaying diagnosis. Non-Hodgkin's lymphoma (NHL) occurs when lymphocytes called T cells and B cells become ...

The American Cancer Society’s most recent estimates for all types of non-Hodgkin lymphoma (NHL) in the United States for 2025 are: 80,350 new cases of NHL (45,140 in men and 35,210 in women) 19,390 ...

The UAB Department of Radiation Oncology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive ...

Radiation therapy may benefit non-Hodgkin lymphoma patients at several stages of the disease In patients with later stage or more aggressive disease, it may be used after rounds of chemotherapy In ...

Treatment is based on the type of T-cell lymphoma and its stage. Treatment options can include chemotherapy, radiation, monoclonal antibodies, and stem cell transplant. Some forms of T-cell lymphoma, ...